251 related articles for article (PubMed ID: 28212503)
1. Lactobacillus buchneri S-layer as carrier for an Ara h 2-derived peptide for peanut allergen-specific immunotherapy.
Anzengruber J; Bublin M; Bönisch E; Janesch B; Tscheppe A; Braun ML; Varga EM; Hafner C; Breiteneder H; Schäffer C
Mol Immunol; 2017 May; 85():81-88. PubMed ID: 28212503
[TBL] [Abstract][Full Text] [Related]
2. Capacity of purified peanut allergens to induce degranulation in a functional in vitro assay: Ara h 2 and Ara h 6 are the most efficient elicitors.
Blanc F; Adel-Patient K; Drumare MF; Paty E; Wal JM; Bernard H
Clin Exp Allergy; 2009 Aug; 39(8):1277-85. PubMed ID: 19538351
[TBL] [Abstract][Full Text] [Related]
3. Single B-cell deconvolution of peanut-specific antibody responses in allergic patients.
Hoh RA; Joshi SA; Liu Y; Wang C; Roskin KM; Lee JY; Pham T; Looney TJ; Jackson KJL; Dixit VP; King J; Lyu SC; Jenks J; Hamilton RG; Nadeau KC; Boyd SD
J Allergy Clin Immunol; 2016 Jan; 137(1):157-167. PubMed ID: 26152318
[TBL] [Abstract][Full Text] [Related]
4. Ara h 2: crystal structure and IgE binding distinguish two subpopulations of peanut allergic patients by epitope diversity.
Mueller GA; Gosavi RA; Pomés A; Wünschmann S; Moon AF; London RE; Pedersen LC
Allergy; 2011 Jul; 66(7):878-85. PubMed ID: 21255036
[TBL] [Abstract][Full Text] [Related]
5. Blockade of peanut allergy with a novel Ara h 2-Fcγ fusion protein in mice.
Liu Y; Sun Y; Chang LJ; Li N; Li H; Yu Y; Bryce PJ; Grammer LC; Schleimer RP; Zhu D
J Allergy Clin Immunol; 2013 Jan; 131(1):213-21.e1-5. PubMed ID: 23199607
[TBL] [Abstract][Full Text] [Related]
6. Natural clinical tolerance to peanut in African patients is caused by poor allergenic activity of peanut IgE.
Wollmann E; Hamsten C; Sibanda E; Ochome M; Focke-Tejkl M; Asarnoj A; Önell A; Lilja G; Gallerano D; Lupinek C; Thalhamer T; Weiss R; Thalhamer J; Wickman M; Valenta R; van Hage M
Allergy; 2015 Jun; 70(6):638-52. PubMed ID: 25683061
[TBL] [Abstract][Full Text] [Related]
7. A phase 1 study of heat/phenol-killed, E. coli-encapsulated, recombinant modified peanut proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the treatment of peanut allergy.
Wood RA; Sicherer SH; Burks AW; Grishin A; Henning AK; Lindblad R; Stablein D; Sampson HA
Allergy; 2013 Jun; 68(6):803-8. PubMed ID: 23621498
[TBL] [Abstract][Full Text] [Related]
8. Monitoring Ara h 1, 2 and 3-sIgE and sIgG4 antibodies in peanut allergic children receiving oral rush immunotherapy.
Nozawa A; Okamoto Y; Movérare R; Borres MP; Kurihara K
Pediatr Allergy Immunol; 2014 Jun; 25(4):323-8. PubMed ID: 24953293
[TBL] [Abstract][Full Text] [Related]
9. The value of specific IgE to peanut and its component Ara h 2 in the diagnosis of peanut allergy.
Lopes de Oliveira LC; Aderhold M; Brill M; Schulz G; Rolinck-Werninghaus C; Clare Mills EN; Niggemann B; Naspitz CK; Wahn U; Beyer K
J Allergy Clin Immunol Pract; 2013; 1(4):394-8. PubMed ID: 24565545
[TBL] [Abstract][Full Text] [Related]
10. The non-specific lipid transfer protein, Ara h 9, is an important allergen in peanut.
Lauer I; Dueringer N; Pokoj S; Rehm S; Zoccatelli G; Reese G; Miguel-Moncin MS; Cistero-Bahima A; Enrique E; Lidholm J; Vieths S; Scheurer S
Clin Exp Allergy; 2009 Sep; 39(9):1427-37. PubMed ID: 19624524
[TBL] [Abstract][Full Text] [Related]
11. Conformational IgE epitopes of peanut allergens Ara h 2 and Ara h 6.
Chen X; Negi SS; Liao S; Gao V; Braun W; Dreskin SC
Clin Exp Allergy; 2016 Aug; 46(8):1120-1128. PubMed ID: 27238146
[TBL] [Abstract][Full Text] [Related]
12. Variable IgE cross-reactivity between peanut 2S-albumins: The case for measuring IgE to both Ara h 2 and Ara h 6.
Hazebrouck S; Guillon B; Paty E; Dreskin SC; Adel-Patient K; Bernard H
Clin Exp Allergy; 2019 Aug; 49(8):1107-1115. PubMed ID: 31108010
[TBL] [Abstract][Full Text] [Related]
13. Walnut allergy in peanut-allergic patients: significance of sequential epitopes of walnut homologous to linear epitopes of Ara h 1, 2 and 3 in relation to clinical reactivity.
Rosenfeld L; Shreffler W; Bardina L; Niggemann B; Wahn U; Sampson HA; Beyer K
Int Arch Allergy Immunol; 2012; 157(3):238-45. PubMed ID: 22042002
[TBL] [Abstract][Full Text] [Related]
14. Expression of a codon-optimised recombinant Ara h 2.02 peanut allergen in Escherichia coli.
Lew MH; Lim RL
Appl Microbiol Biotechnol; 2016 Jan; 100(2):661-71. PubMed ID: 26411458
[TBL] [Abstract][Full Text] [Related]
15. Analysis of cytokine production by peanut-reactive T cells identifies residual Th2 effectors in highly allergic children who received peanut oral immunotherapy.
Wisniewski JA; Commins SP; Agrawal R; Hulse KE; Yu MD; Cronin J; Heymann PW; Pomes A; Platts-Mills TA; Workman L; Woodfolk JA
Clin Exp Allergy; 2015 Jul; 45(7):1201-13. PubMed ID: 25823600
[TBL] [Abstract][Full Text] [Related]
16. Ara h 2 is the dominant peanut allergen despite similarities with Ara h 6.
Hemmings O; Du Toit G; Radulovic S; Lack G; Santos AF
J Allergy Clin Immunol; 2020 Sep; 146(3):621-630.e5. PubMed ID: 32298698
[TBL] [Abstract][Full Text] [Related]
17. Lipid transfer protein (Ara h 9) as a new peanut allergen relevant for a Mediterranean allergic population.
Krause S; Reese G; Randow S; Zennaro D; Quaratino D; Palazzo P; Ciardiello MA; Petersen A; Becker WM; Mari A
J Allergy Clin Immunol; 2009 Oct; 124(4):771-8.e5. PubMed ID: 19665774
[TBL] [Abstract][Full Text] [Related]
18. Early decrease in basophil sensitivity to Ara h 2 precedes sustained unresponsiveness after peanut oral immunotherapy.
Patil SU; Steinbrecher J; Calatroni A; Smith N; Ma A; Ruiter B; Virkud Y; Schneider M; Shreffler WG
J Allergy Clin Immunol; 2019 Nov; 144(5):1310-1319.e4. PubMed ID: 31377342
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy using algal-produced Ara h 1 core domain suppresses peanut allergy in mice.
Gregory JA; Shepley-McTaggart A; Umpierrez M; Hurlburt BK; Maleki SJ; Sampson HA; Mayfield SP; Berin MC
Plant Biotechnol J; 2016 Jul; 14(7):1541-50. PubMed ID: 26801740
[TBL] [Abstract][Full Text] [Related]
20. Influence of age on IgE response in peanut-allergic children and adolescents from the Mediterranean area.
Garcia-Blanca A; Aranda A; Blanca-Lopez N; Perez D; Gomez F; Mayorga C; Torres MJ; Diaz-Perales A; Perkins JR; Villalba M; Blanca M; Canto G
Pediatr Allergy Immunol; 2015 Sep; 26(6):497-502. PubMed ID: 26046378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
